V Wealth Advisors LLC Biogen Inc. Transaction History

V Wealth Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 27, 2021	BUY	$259.0 - $414.71 $164,724 - $263,755	636 New	636 $220,000
Q1 2019 May 16, 2019	SELL	$216.71 - $338.96 $139,127 - $217,612	-642 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$278.5 - $352.75 $13,089 - $16,579	47 Added 7.9%	642 $209,000
Q3 2018 Oct 31, 2018	BUY	$293.51 - $383.83 $174,638 - $228,378	595 New	595 $212,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of V Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on V Wealth Advisors LLC with notifications on news.